CR Pharmaceutical Commercial Completes RMB1.40 Billion Second-Tranche 2026 Bond Offering

Bulletin Express04-28

China Resources Pharmaceutical Group Limited’s subsidiary, CR Pharmaceutical Commercial, has finalized the public issuance of the second tranche of its 2026 corporate bonds in mainland China. The offering raised RMB1.40 billion with a three-year tenor and an annual coupon rate of 1.65%.

According to the announcement, net proceeds will be directed toward production expenditures, including working-capital replenishment, repayment of interest-bearing debt and project investment, in accordance with relevant regulations.

The transaction follows the first-tranche issuance disclosed on 27 March 2026, completing the group’s planned onshore financing for the 2026 series.

Shareholders and prospective investors are advised to exercise caution when trading the securities of China Resources Pharmaceutical Group Limited.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1151131522?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-28 17:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1151131522","market":"hk","top_or_hot":-1,"title":"CR Pharmaceutical Commercial Completes RMB1.40 Billion Second-Tranche 2026 Bond Offering","media":"Bulletin Express","content":"<p>China Resources Pharmaceutical Group Limited’s subsidiary, CR Pharmaceutical Commercial, has finalized the public issuance of the second tranche of its 2026 corporate bonds in mainland China. The offering raised RMB1.40 billion with a three-year tenor and an annual coupon rate of 1.65%.</p>\n<p>According to the announcement, net proceeds will be directed toward production expenditures, including working-capital replenishment, repayment of interest-bearing debt and project investment, in accordance with relevant regulations.</p>\n<p>The transaction follows the first-tranche issuance disclosed on 27 March 2026, completing the group’s planned onshore financing for the 2026 series.</p>\n<p>Shareholders and prospective investors are advised to exercise caution when trading the securities of China Resources Pharmaceutical Group Limited.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CR Pharmaceutical Commercial Completes RMB1.40 Billion Second-Tranche 2026 Bond Offering</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCR Pharmaceutical Commercial Completes RMB1.40 Billion Second-Tranche 2026 Bond Offering\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-28 17:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>China Resources Pharmaceutical Group Limited’s subsidiary, CR Pharmaceutical Commercial, has finalized the public issuance of the second tranche of its 2026 corporate bonds in mainland China. The offering raised RMB1.40 billion with a three-year tenor and an annual coupon rate of 1.65%.</p>\n<p>According to the announcement, net proceeds will be directed toward production expenditures, including working-capital replenishment, repayment of interest-bearing debt and project investment, in accordance with relevant regulations.</p>\n<p>The transaction follows the first-tranche issuance disclosed on 27 March 2026, completing the group’s planned onshore financing for the 2026 series.</p>\n<p>Shareholders and prospective investors are advised to exercise caution when trading the securities of China Resources Pharmaceutical Group Limited.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03320","symbol_name":"华润医药","start_time":0,"source_url":"","article_id":"1151131522","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1151131522","pubTimestamp":1777369435,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"China Resources Pharmaceutical Group Limited’s subsidiary, CR Pharmaceutical Commercial, has finalized the public issuance of the second tranche of its 2026 corporate bonds in mainland China. The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03320":"华润医药"},"translate_title":"华润医药商业完成人民币14亿元2026年第二期债券发行","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03320":1},"content_text":"China Resources Pharmaceutical Group Limited’s subsidiary, CR Pharmaceutical Commercial, has finalized the public issuance of the second tranche of its 2026 corporate bonds in mainland China. The offering raised RMB1.40 billion with a three-year tenor and an annual coupon rate of 1.65%.\nAccording to the announcement, net proceeds will be directed toward production expenditures, including working-capital replenishment, repayment of interest-bearing debt and project investment, in accordance with relevant regulations.\nThe transaction follows the first-tranche issuance disclosed on 27 March 2026, completing the group’s planned onshore financing for the 2026 series.\nShareholders and prospective investors are advised to exercise caution when trading the securities of China Resources Pharmaceutical Group Limited.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1151131522","isCrawlerRequest":true}